Leonie Ratz
Leonie Ratz is an expert in Oncology at Max Planck Institute for Biology of Ageing (Germany). Leonie Ratz has authored 9 publications, the most recent in 2025. SLR score: 29 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 9
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Revisiting Genomic Instability, Tumor Microenvironment and Immune Response in High-Grade Serous Ovarian Cancer. PMID 40599900 — cells, neoplasms, ovarian neoplasms, genomic instability, immunity, therapeutics, tumor microenvironment | Geburtshilfe Frauenheilkd | 2025 | 0 |
| Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. PMID 35715861 — cells, breast neoplasms, pharmaceutical preparations, neoplasms, drug combinations, breast, therapeutics, genes, brca1 | Breast Cancer Res | 2022 | 15 |
| Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53. PMID 32674955 — genes, p53, prostate, apoptosis, cellular senescence, dna, cells, prostatic neoplasms | Urol Oncol | 2020 | 5 |
| EZH2 Inhibition Sensitizes BRCA1-Deficient Breast Cancer to Synthetic Lethal Therapy with ATM Inhibitors OpenAlex W4237297476 — cells, breast neoplasms, neoplasms, drug combinations, breast, therapeutics, genes, brca1 | Research Square (Research Square) | 2021 | 0 |
| Repression Leads to Enhanced NOTCH Signaling in Fusion Positive Prostate Cancer Cells. PMID 33669024 — prostate, cells, prostatic neoplasms, genes, repression, psychology, epigenomics | Cancers (Basel) | 2021 | 9 |
LeadR Networks
Main global connection map